Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We had the biggest announcement in Elite history this year, we launched generic Adderall XR with annual sale of $1.3 Billion. Sorry, Elite is not a news company to come with announcement every day or month!
Btw, can you show me a tiny pharma company which is in OTC market and had launched generic drugs for $2 billion market? Show me some example.
Numbers Never Lie!
Stay Long, Be Elite!
Nothing can change the facts that we are playing in a $2 Billion CNS market now, simple and easy. We are in the right direction to have $160 - $180M revenue annually just from CNS Adderall IR and Aderall XR. All those opiods drugs combined annual sale was $1 Billion market. So, it was a smart move. Meanwhile, we still have Opiods in our portofolio like SequestOx, Generic Oxycontin, etc but for now we have our focus on CNS. We put them in back burner for now. It is totally logical.
Numbers Never Lie!
Stay long and strong
Exactly, if you are here then you care. Just be patient. There is another option too
Record Breaking Revenue in Elite's history.
All great predictions!
As I like the NUMBERS, just adding a fact number here. Did you know Elite revenue at 2019 was $7.5 Mil. That means at 2021 we will have at least 4 times of 2019 revenue. Numbers Never Lie!
What a great team at Elite including its smart CEO.
Stay Long. Stay Strong.
Great Times Ahead!
He led us to a $2 billions CNS market, Aderall IR and XR. So, with a similar prorated market share capture for Elite, that would be roughly $160 - $180M a year at peak, or roughly double the pain meds.
Numbers never lie!
From no2koolaid:
While the numbers being thrown around for the cost of development are speculative, it would be informative if we can look at the alleged $50 Million market opportunity of the pain meds and the actual mathematical percentage that a prorated share of the market at peak would allow:
Percocet: 16 competitors with equal prorated market share of 6.25%/500 = 31.250 M
Norco: 11 competitors with equal prorated market share of 0.91% / 447 = 40.680 M
Ty w/code: 8 competitors with equal prorated market share of 12.5% / 45 = 5.630 M
Methadone: 10 competitors with equal prorated market share of = 10.0% / 30 = 3.00 M
Hydromorphone: 8 competitors with equal prorated market share of = 12.5% / 30 = 3.750 M
In aggregate, the prorated market share for an owner of the drugs at peak would be more than $50M, it would be = $84.310 M.
OBTW: The $1.2 Million Elite got for the sale of the drugs to Nostrum was put to good business use, since the p/s was being manipulated to keep it under the dime needed to sell shares to LPC and fund development.
But it is more complicated than the simple math suggests...
Beyond that the "$50M" argument fails to account for time to peak revenues, it also fails to account for the need of a partner to commercialize the drugs. Whether Elite was unable to find a partner at a reasonable price, or at all, would affect certain strategic decisions; which might well have influenced Elite's pivot to the CNS generics. Further, what might have influenced that pivot was, in no small part, because of a comparative look at the market opportunity with generic Adderall IR and XR.
According to the much discussed IQVIA numbers…generic Adderall IR and XR are thought to have a combined market of $1.8-2.0 Billion. So, with a similar prorated market share capture for Elite, that would be roughly $160 - $180M a year at peak, or roughly double the pain meds above. To even the untrained business eye, the math suggests that Elite’s pivot was financially correct, as it will have turned the pivot into profit.
Elite facility is actually PERFECT. Do you remember how many pills we can make with our dryers? It is all about numbers.
Numbers never lie!
Actually Nasrat is very smart. He changed Elite and now we are selling two CNS drugs , Adderall IR and Aderall XR, in $2 Billion market.
Smart CEO.
Stay long and strong!
He is very smart CEO. He knows a tiny company like Elite in OTC get manipulated for short-term gain. But look at numbers, less than 1 million shares get traded daily out of 900 million. Why? Because long term investors are not selling!
Stay long and strong!
Thanks no2koolaid for the great post. I always appreciate your intel which comes with facts and numbers.
I see a lot of complaining why pain ANDAs never got materialized, thanks for thoughtful answer. As you said switching to CNS was a good decision and with the same prorated market share we will double the revenue compare to pain drugs.
This amazes me too!
Cheers
Nasrat is a great CEO. The company would have been bankrupt if he wouldn't change the direction from opioid to CNS. Plus this stock is in OTC and get manipulate it for short term gain by day traders.
Here are some additional data to make it easier!
Lannett's debt is $705 Millions with Market cap of $246 Millions so Debt to Market Cap ratio is 705/246 = 280%
Elite's debt is $4 Millions with Market cap of $58 Millions so Debt to Market Cap ratio is 4/58 = 7%
Do you see the difference, it is very simple. This amazes me too!
Stay long and strong.
"The stock market is a device for transferring money from the impatient to the patient." - Warren Buffett
He is right. Remember he doesn't care about day traders. He said it to longterm investors.
Stay long and strong.
"The stock market is a device for transferring money from the impatient to the patient." - Warren Buffett
It will be record breaking revenue. Great job to Elite team including his great CEO, Nasrat Hakim.
He deserves every penny. The company would have been bankrupt if he wouldn't change the direction from opioid to CNS.
Here are some additional data to make it easier!
Lannett's debt is $705 Millions with Market cap of $246 Millions so Debt to Market Cap ratio is 705/246 = 280%
Elite's debt is $4 Millions with Market cap of $58 Millions so Debt to Market Cap ratio is 4/58 = 7%
Do you see the difference, it is very simple. This amazes me too!
Stay long and strong.
"The stock market is a device for transferring money from the impatient to the patient." - Warren Buffett
Thanks to our great CEO who led us to this record-breaking revenue!
Numbers never lie!
Stay long and strong
Thanks to our great CEO who led us to this record-breaking revenue!
Numbers never lie!
Stay long and strong
This shows how undervalued Elite is. Number of shares that get traded is almost nothing, 1 mil out of 900mil.
Numbers never lie!
Stay long and strong
My pleasure to clarify it for you. As I said I made it easier to understand.
Now let's add another fact to the equation...
Elite revenue in 2021 next year would be minimum 4x$7 = $28 millions and its market cap is $58 million. Not many companies out there their revenue is 50% of their market cap! This fact amazes me too.
Numbers never lie!
Stay long and strong
You're welcome. Now let's add another fact to the equation...
Elite revenue in 2021 next year would be minimum 4x$7 = $28 millions and its market cap is $58 million. Not many companies out there their revenue is 50% of their market cap! This fact amazes me too.
Numbers never lie!
Stay long and strong
Here are some additional data to make it easier!
Lannett's debt is $705 Millions with Market cap of $246 Millions so Debt to Market Cap ratio is 705/246 = 280%
Elite's debt is $4 Millions with Market cap of $58 Millions so Debt to Market Cap ratio is 4/58 = 7%
Do you see the difference, it is very simple. This amazes me too!
Stay long and strong.
"The stock market is a device for transferring money from the impatient to the patient." - Warren Buffett.
Yes, and Elite revenue in 2021 next year would be minimum 4x7 = $28 millions and its market cap is $58 million. Not many companies out there their revenue is 50% of their market cap! This amezes me too.
Stay long and strong
Agreed.
"The stock market is a device for transferring money from the impatient to the patient." - Warren Buffett.
Good point Ryan, nobody selling. 1 million out of 900 million OS is nothing. That is the reason you hear fear get spread maybe a weak hand drops their shares. Not happening:)
Stay long and strong. We are closer than ever!
"The stock market is a device for transferring money from the impatient to the patient." - Warren Buffett.
Welcome back Couch!
Not me. Talk for yourself.
A hint: Never ask that question from any publicly traded company, Elite or any other you may have owned. It just doesn't look good for you! You know that "YOU" DECIDED to be shareholder here, you can DECIDE to sell and move on if you don't like this company or his CEO. Always rememeber it is your OWN CHOICE.
My opinion is on generic Concentra and Generic Oxycontin ADT
Another great post no2koolaid. I agree it is foolish to ask Nasrat to resign after he turned around Elite from Opioid unknown to CNS market with launch of Adderalls, $1.7 billion market. Plus over 75% of shareholders voted "FOR" him just a couple months ago on what he proposed.
Our CEO has more important tasks to focus like increasing our maket share on Adderall IR and XR. Getting generic Concerta to the stage that he wants. No time for answering BS questions.
Stay Long, Stay Strong.
Cheers
Great post no2koolaid! Nasrat's wise decision would benefit all shareholders. NASDAQ2020 brought up a good point, Sungen didin't like share offering but Nasrat will and that's how Adderall drugs will be owned by Elite soon and Nasrat will take some shares. Win-Win deal.
Another great post no2koolaid! With Opioid lawsuit crisis and FDA hurdles for Elite on SequestOx, Elite left with a few small drugs until April 2019. Our CEO turned around Elite and launched generic Adderall IR and XR and now we are back to business in $1.7 billion market, in fact one quarter of Elite Adderall IR sale with minimal penetration is almost equivalent to all other Elite's drugs sale combined. Below table is a good reminder! I believe it is unfair for bashing him why he didn't lend money to Elite to be sole owner of generic Adderalls. Seems odd but not surprising!
Btw, my 2 cents re why Mikah had to step in, of course my opinion and just speculating here: We were in a race to get the Adderall drugs off the street as Sungen was negotiating with Chinese companies or others, per CC, so Nasrat had to pull the trigger with Mikah and sign the deal asap with Sungen CEO before any other competitor give him any offer. I assume through Elite the process would be slower and we would miss our first shot at it. Just my opinion.
Hey NASDAQ2020: This is updated table based on the new info from recent CC. Let me know if anything should be changed.
Thank you very much no2koolaid. It is a great pleasure reading your posts! As you mentioned some stuffs are still brewing and we will hear them when the time is right and as Nasrat said in the last CC.
Hope you had a great 4th of July!
Cheers
I think everyone understand here we don't have ANY legal ground to know details about the transaction between two private companies, Sungen and Mikah. PERIOD.
I suggest King as he is worried the most and vocal about it, to contact Dianne and see if there is any conflict of interest here. Thanks in advance King!
My personal opinion regarding to Adderall IR and Adderall XR transaction, Sungen with China connection was a partner with Elite but now Mikah a US based company is the partner. I see this is as positive sign.
What about if one day we all become Mikah shareholders?!! Just throwing the idea out there. Reverse merger of Mikah and Elite.
I hope to get some thoughts from Winechemist, No2Koolaid or Weezuhl about reverse merger theory.
Great post! Glad to see you here after a few months.
Have a great weekend as well and stay safe and healthy.
Obviously some shareholders are pissed but they are minority. MAJORITY of shareholders , over 85%, voted FOR.
I see the recording of yesterday meeting and downloaded. How come you don't see it? I use Chrome.
UPDATED REMINDER: List of ELTP Filed Drugs with FDA and more
Warren Buffett has said, "The stock market is a device for transferring money from the impatient to the patient."
Stay Long, Stay Strong!
(NASDAQ2020: Thanks for all updates. This should be final, let me know if anything else should be updated.)
REMINDER: List of ELTP Filed Drugs with FDA and more
Warren Buffett has said, "The stock market is a device for transferring money from the impatient to the patient."
Stay Long, Stay Strong!
(NASDAQ2020: Thanks for the updates. Can you send me the links for updates for Methadone, Phendimetrazine and PDFUA date for Codeine with acetomenophen)
Some Elite and Lannett labels for Generic Adderall XR! GLTA
Elite and Lannett labels
My prediction is $6.6 million.
I totally remember that drug that was pull out by FDA. Nasrat turned around this company